Cancer Research AACR Membership  Telomeres
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 46, 5035-5038, October 1, 1986]
© 1986 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Crook, T. R.
Right arrow Articles by McLean, A. E. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Crook, T. R.
Right arrow Articles by McLean, A. E. M.

Glutathione Depletion as a Determinant of Sensitivity of Human Leukemia Cells to Cyclophosphamide

Tim R. Crook1, Robert L. Souhami2, Gillian D. Whyman and A. E. M. McLean

Toxicology Laboratory, School of Medicine, University College London, London, WC1 6JF [T. R. C., G. D. W., A. E. M. M.], and Department of Radiotherapy and Oncology, University College Hospital, Gower Street, London, WC1 [R. L. S.], England

The role of glutathione (GSH) as a determinant of cellular sensitivity to the cytotoxic and DNA-damaging effects of cyclophosphamide (CP) was studied in a dual culture system of rat hepatocytes and K562 human chronic myeloid leukemia cells, which have elevated aldehyde dehydrogenase activity with a corresponding insensitivity to activated CP.

Exposure of K562 cells to 50 µM DL-buthionine-S,R-sulfoximine for 24 h resulted in a depletion of cellular GSH content to 10% of control values without toxicity. Subsequent 1-h exposure of GSH-depleted cells to activated cyclophosphamide, obtained by incubation of CP with suspension cultures of rat hepatocytes, resulted in a 5-fold potentiation of the cytotoxicity of CP. Alkaline elution analysis of cellular DNA demonstrated that the level of apparent interstrand cross-linking was 3 to 4 times higher in GSH-depleted cells than in nondepleted cells. GSH-depleted cells were, in addition, more sensitive to induction of DNA single strand breaks than nondepleted cells. Depletion of GSH content did not increase cellular sensitivity to the cytotoxicity of phosphoramide mustard. Preincubation of K562 cells with 1 mM cysteine for 4 h resulted in an approximately 60% increase in cellular GSH content, which was accompanied by decreased sensitivity to the cytotoxicity of hepatocyte-activated CP.

Exposure of nondepleted cells to clinically relevant concentrations of hepatocyte-activated CP resulted in depletion of cellular GSH content. Replenishment of GSH content in these cells was relatively slow following CP exposure. Acrolein was highly effective at depleting cellular GSH content, whereas phosphoramide mustard had no effect on cellular GSH content. The depletion of GSH by intracellularly released acrolein may be important in the mechanism of cytotoxicity of CP.

1 Recipient of support from the Trustees of the Wagner Foundation and the Special Trustees of University College Hospital for funding a studentship.

2 To whom requests for reprints should be addressed.

Received 2/12/86. Revised 6/10/86. Accepted 6/12/86.




This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
K. A. Tacka, J. C. Dabrowiak, J. Goodisman, and A.-K. Souid
Kinetic Analysis of the Reactions of 4-Hydroperoxycyclophosphamide and Acrolein With Glutathione, Mesna, and Wr-1065
Drug Metab. Dispos., August 1, 2002; 30(8): 875 - 882.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Cai, M. H. Wu, S. M. Ludeman, D. J. Grdina, and M. E. Dolan
Role of O6-Alkylguanine-DNA Alkyltransferase in Protecting against Cyclophosphamide-induced Toxicity and Mutagenicity
Cancer Res., July 1, 1999; 59(13): 3059 - 3063.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. Ochs, R. W. Sobol, S. H. Wilson, and B. Kaina
Cells Deficient in DNA Polymerase {beta} Are Hypersensitive to Alkylating Agent-induced Apoptosis and Chromosomal Breakage
Cancer Res., April 1, 1999; 59(7): 1544 - 1551.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1986 by the American Association for Cancer Research.